Adam Goldman
Sheba Medical Center(IL)
Publications by Year
Research Areas
CAR-T cell therapy research, Pharmacovigilance and Adverse Drug Reactions, Pneumonia and Respiratory Infections, Pharmaceutical Economics and Policy, Sepsis Diagnosis and Treatment
Most-Cited Works
- → The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration(2024)229 cited
- → The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement(2024)147 cited
- → Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy(2021)141 cited
- → Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports(2020)55 cited
- → Ocular Adverse Events Induced by Immune Checkpoint Inhibitors: A Comprehensive Pharmacovigilance Analysis(2020)54 cited
- → The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study(2023)40 cited
- → Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19(2021)35 cited
- → Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study(2021)35 cited
- → Incidental abnormal ECG findings and long-term cardiovascular morbidity and all-cause mortality: A population based prospective study(2019)30 cited
- → Cardiovascular Toxicities of Antiangiogenic Tyrosine Kinase Inhibitors: A Retrospective, Pharmacovigilance Study(2021)28 cited